US · Healthcare · Drug Manufacturers - General
EPS came in at 8.55 against a street estimate of 6.79 — a beat of 25.9%.
Analysts rate Eli Lilly and Company a buy (24 buy, 5 hold, 2 sell out of 31) with an average price target of $1,276.96.
| Fund | Stake |
|---|---|
| Lilly Endowment Inc | 10.13% |
| BlackRock Inc | 7.44% |
| Vanguard Capital Management, LLC | 5.98% |
| PNC Financial Services Group Inc | 5.76% |
| State Street Corp | 3.99% |
| FMR Inc | 2.95% |
| Capital Research Global Investors | 2.76% |
| Vanguard Portfolio Management, LLC | 2.35% |
| Document | Date |
|---|---|
| Company announcement · Q2 2026 | 2026-05-20 |
| Shareholder vote results · Q2 2026 | 2026-05-07 |
| Quarterly report · Q1 2026 | 2026-04-30 |
| Results announced · Q2 2026 | 2026-04-30 |
| Proxy statement · Q1 2026 | 2026-03-20 |
| Annual report FY2025 | 2026-02-12 |
| Results announced · Q1 2026 | 2026-02-04 |
| Quarterly report · Q3 2025 | 2025-10-30 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $1.73 / share ex-date Aug 14, 2026 · pay Sep 10, 2026 | 2026-08-14 |
| Dividend | $1.73 / share ex-date May 15, 2026 · pay Jun 10, 2026 | 2026-05-15 |
| Dividend | $1.73 / share ex-date Feb 13, 2026 · pay Mar 10, 2026 | 2026-02-13 |
| Dividend | $1.50 / share ex-date Nov 14, 2025 · pay Dec 10, 2025 | 2025-11-14 |
| Dividend | $1.50 / share ex-date Aug 15, 2025 · pay Sep 10, 2025 | 2025-08-15 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Eli Lilly and Company — free to start.
Google PlayApp StoreData updated 2026-08-05.